Gloucestershire Hospitals Nhs Foundation Trust

The FDA granted marketing authorization for the Versius Surgical System, a versatile, adaptable, and digitally driven surgical robot, through its De Novo process, establishing its initial indication for adult cholecystectomy. Versius, the second most utilized surgical robotic system globally, has completed over 26,000 procedures across various regions. Its compact design and portability aim to increase surgical options in the U.S., offering benefits such as 3D HD vision, ergonomic working positions, and a suite of digital apps for real-time insights.